New Graves' drug enters first human safety trial
Disease control
Recruiting now
This early-stage study tests a new drug called MER511 in 100 adults with Graves' disease. The main goal is to see if the drug is safe and what side effects it may cause. Participants will receive the drug either through a vein or under the skin, and blood tests will check how the…
Phase: PHASE1 • Sponsor: Merida Biosciences • Aim: Disease control
Last updated May 17, 2026 04:08 UTC